中譽集團(00985.HK)擬1.5億港元收購澳門酒店Uni-Dragon10%權益
格隆匯10月15日丨中譽集團(00985.HK)宣佈,於2019年10月15日,公司間接全資附屬公司逸領擬向Falloncrof收購購Uni-Dragon 10%股權及其所欠股東貸款,現金代價為1.5億港元。其間接擁有新聯生的全部股權,而新聯生擁有位於澳門路氹金光大道,為一間建築面積約945,079平方尺的奢華酒店,設有約200間複式套房及餐廳。
收購事項為集團投資澳門物業市場提供機遇。董事考慮到有關投資將有利於集團現有投資組合的多元化及拓闊集團收入,併為集團提升及創造長遠裨益。董事鑑於上述理由及裨益,相信收購協議及股東協議之條款屬公平合理並符合公司及股東的整體利益。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.